China Healthcare and Medicine Tenders

China's healthcare and medicine market is a behemoth, projected to reach a whopping $1.6 trillion by 2025. This makes it the world's second-largest market after the US.
Key figures:
Market size: $1.6 trillion (projected for 2025)
Growth rate: 8.3% CAGR (2021-2026)
Drivers: aging population, rising disposable incomes, government support

The Chinese government is a major player in the healthcare market, accounting for over 50% of total healthcare spending. This translates to an annual procurement budget of over $500 billion.
Key figures:
Procurement budget: $500+ billion annually
Share of total healthcare spending: 50%+

The Chinese government procures a wide range of healthcare and medicine products and services, including:
Pharmaceuticals: generic drugs, biologics, vaccines
Medical devices: diagnostics, imaging equipment, surgical instruments
Healthcare services: hospital care, outpatient care, preventive care

Several authorities oversee China's healthcare and medicine procurement, including:
National Health Commission (NHC): sets overall policies and guidelines
Ministry of Finance (MOF): manages the budget and approves large purchases
Public hospitals: have significant autonomy in procuring supplies and services

Chinese and international companies alike are vying for a piece of the pie in China's healthcare procurement market. Some of the top winners include:
Domestic companies: Sinopharm, China National Medical Device Co., Ltd. (CNMED)
International companies: Johnson & Johnson, GE Healthcare, Philips

Tags -
China healthcare medicine tenders, free China healthcare medicine tenders, government healthcare medicine tenders China, China Hospital supply tenders, China healthcare consultancy tenders, China medicine tenders, China hospital tenders, China drugs tenders, China health services tenders